|
Scimitar Equity, LLC, Inc (Scimitar) is a publisher of investment equity research utilizing the "sponsored" or "paid-for" compensation model to increase visibility and access
for the health science sector specific companies. Scimitar does receive compensation for research coverage services. Scimitar has been paid a fee for preparing "Informational Reviews",
"Quarterly Review" and "Mid-Quarter" Update(s). These reviews and updates display statements of "sponsorship" to maximize transparency standards in analyst certification in each review.
Scimitar "clearly and prominently" articulates this statement of financial sponsorship in the Disclosure section (in each review) in the last two pages of every review and that it has
a compensation arrangement for these informational ($25,000), quarterly ($8,500) and mid-quarter update ($4,500) research reviews. Scimitar discloses potential conflicts of interest
insuring objectivity. Scimitar and Henry McCusker will not accept payment of any fees in company stock or any form of securities under any alternative payment methods that could
compromise the objectivity and integrity of any informational, quarterly and mid-quarter update(s) analysis. Scimitar delivers this research and analysis of selected segments within
the health/life science industry via the world-wide web, Thomson Financial and our proprietary database to the institutional, advisory and retail investment communities. Scimitar
makes publicly available an excel format statement of yearly payments by covered companies. Scimitar has prepared this downloadable excel format to include; subject company, the
current full year indicating the period(s) and a breakdown of the services provided for which such payment(s) are applicable (e.g., 2004, 2005 etc.). The attached PDF data is
provided in an Excel spreadsheet.
2007 Downloadable Excel Format
|
